Searching High and Low: Call for a Joint European Society for Paediatric Infectious Diseases-European Committee on Antimicrobial Susceptibility Testing Survey on Dosage of Antibacterial Agents in Children-Part One.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read More Add to Saved list
  • Additional Information
    • Source:
      Publisher: Williams & Wilkins Country of Publication: United States NLM ID: 8701858 Publication Model: Print Cited Medium: Internet ISSN: 1532-0987 (Electronic) Linking ISSN: 08913668 NLM ISO Abbreviation: Pediatr Infect Dis J Subsets: MEDLINE
    • Publication Information:
      Original Publication: [Baltimore, Md. : Williams & Wilkins, c1987-
    • Subject Terms:
      Anti-Bacterial Agents*/pharmacology ; Anti-Bacterial Agents*/therapeutic use ; Communicable Diseases*/drug therapy; Child ; Humans ; Infectious Disease Medicine ; Microbial Sensitivity Tests ; Societies
    • Abstract:
      Competing Interests: The authors have no funding or conflicts of interest to disclose.
    • References:
      Mouton JW, Brown DF, Apfalter P, et al. The role of pharmacokinetics/pharmacodynamics in setting clinical MIC breakpoints: the EUCAST approach. Clin Microbiol Infect. 2012;18:E37–E45.
      Brown D, Canton R, Dubreuil L, et al. Widespread implementation of EUCAST breakpoints for antibacterial susceptibility testing in Europe. Euro Surveill. 2015;20:21008.
      Giske CG, Turnidge J, Cantón R, et al. Update from The European Committee On Antimicrobial Suseptibility Testing (EUCAST) [published online ahead of print August 4, 2021]. J Clin Microbiol. 2021;doi: 10.1128/JCM.00276-21. (PMID: 10.1128/JCM.00276-21)
      EUCAST. Clinical breakpoints and dosing of antibiotics. 2021. Available at: https://www.eucast.org/clinical_breakpoints/ . Accessed June 7, 2021.
      Clements MN, Russell N, Bielicki JA, et al. Global antibiotic dosing strategies in hospitalised children: characterising variation and implications for harmonisation of international guidelines. PLoS One. 2021;16:e0252223.
    • Accession Number:
      0 (Anti-Bacterial Agents)
    • Publication Date:
      Date Created: 20220214 Date Completed: 20220419 Latest Revision: 20230912
    • Publication Date:
      20240104
    • Accession Number:
      10.1097/INF.0000000000003457
    • Accession Number:
      35153290